AIM Breakfasts

AIM BREAKFAST – 4th August 2016

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 1,015

Total number of AIM Companies trading: 990*
* As at 30 June 2016

Dish of the Day:

No Primary Today

Off the Menu:

No Leavers Today

Set Menu ISDX Growth:

Total number of ISDX Growth Market Companies (Incl Susp): *

Total number of ISDX Growth Market Companies trading: *
* As at 30 June 2016

Dish of the Day:

Off the Menu:

What’s Cooking in the IPO Kitchen?

Franchise Brands (FRAN.L) confirmed it will join AIM on Friday. £3.5m raise at 33p oversubscribed. 15.6m market cap. Currently focusses  on car paintwork repair and domestic cleaning.  2015 – £4.4m rev/£1.1m PBT

The Intertain Group Ltd – World’s largest online bingo-led operator (on TSX) intends to join Official List

Autins Group plc – The acoustic and thermal insulation specialist  looks to join AIM early August


Breakfast Buffet

Magnolia Petroleum (MAGP.L) 0.16p £2.04m

The  US onshore focused oil and gas exploration and production company  has announced a £250k placing at 0.1p, a 37.5% discount to yesterday’s close. The proceeds of the Placing will be used to fund current drilling commitments on its acreage in proven US onshore hydrocarbon formations, such as the Woodford and Mississippi Lime in Oklahoma.


Metal Tiger (MTR.L) 3.52p £19.5m

The investor in strategic natural resource projects has announced its quarterly activities report.  Active investment programme—£700k contributed to direct placings including Greatland Gold, and Conroy Gold & Natural Resources*.  Resource drilling underway at Botswanan JV. Discussions underway for interests in Thai Silve-Lead-Zinc mines. Working capital strong at circa £4m.


Metminco (MNC.L) 0.186p £m

The exploration and mining company  has agreed an (up to) $45m equity funding agreement for its Los Calatos Copper-Molybdenum Project in Peru. This is with a UK mining fund managed by CD Capital who will hold a 70% stake in the project.  The Project has a Mineral Resource of 352Mt at 0.76% Cu (2.7 million tonnes of copper) and 0.032% Mo (0.11 million tonnes molybdenum) in the Measured, Indicated and Inferred Mineral Resource categories.  The funds will be used to complete the planned Pre-Feasibility and Feasibility Studies on the Project .


ReNeuron Group (RENE.L) 3.15p £99.69m

The developer of cell-based therapeutics  has announced the publication of long term follow up data from its PISCES I stroke clinical trial in The Lancet. As previously reported, improvements in neurological status and limb function compared with pre-treatment baseline performance were observed within three months of treatment and maintained throughout long term follow up. There were no cell-related or immunological adverse events reported in any of the patients treated in the PISCES I study across the four ascending dose levels.


Global Invacom Group (GINV.L) 7.5p £19.5m

The satellite communications (“Sat Comms”) equipment provider  has published H1 and Q2 results. Q2 has seen a $2.1m swing from a $1.9m net loss to a small profit of $0.2m. Highlights included two major orders from telecommunications providers and suppliers in the U.S. and Indonesia . Half year revenues were $64.3m up 19.1%. Consensus numbers are looking for FY Dec 2016 revenues of $195.6m and PBT of $4.05m.


Matchtech Group (MTEC.L) 337.6p £104.4m

The UK specialist Engineering and Technology (IT & Telecoms) recruitment agency  has updated on trading for FY July 2016. The Board expects profits to be in-line with its previous expectations. Net Fee Income up 34% but only 1% on a like for like basis stripping out the Networkers acquisition completed in April 2015.  On a like for like basis Engineering was up 6% and Technology down 6%. ‘Demand for skilled engineers remains strong in the UK and, notably, we have yet to see any impact on vacancy flow in the six weeks since the EU Referendum.’ The shares are on 7.4x FY16E EPS.


ServicePower Tech (SVR.L) 5.5p £5.69m

The mobile workforce management software developer and provider has  provided an H1 June 2016 trading update. Trading for the half-year is in-line with management expectations with positive momentum at the period end, driven by improved gross margin, with June being EBITDA and net income positive. Total revenue  up 4.9% to £6.4m. 98% recurring revenue! Cash balances remain flat at £0.7m. Plenty of product innovation in the period. The shares have underperformed over the last year and trade at under 0.5x FY2016e revenues.


Mytrah Energy (MYT)

The India-based renewable focused Independent Power Producer,  has announced that a majority owned subsidiary has entered an agreement with an investment vehicle of GE (NYSE:GE)  who will invest up to $31m to support the development of a 200 MW wind energy project in Andhra Pradesh.  The shares are on a 9.8x PE and have a projected yield of 1.4% based on FY2016 consensus forecasts.


Portmeirion Group (PMP.L) 912.5p £98.24m

The homewares group whose brands include Portmeirion and Royal Worcester has reported interims to June 2016. Revenue of £28.5 million up by 2% on the comparative period.   PBT down by 22% to £1.4 million. Interim dividend up 15% to 7p. Completed £17.5 million acquisition of Wax Lyrical Limited, the UK’s largest manufacturer of home fragrances. Net debt £9.7m. Following the 7 July profit warning Asian markets remain tough. EU referendum not hit retail but wholesale was impacted. The company believes this to be short term. The FY16E PE is 16x.


ANGLE (AGL.L) 63.5p £47.49m

ANGLE has announced a poster presentation by researchers from the University of Texas MD Anderson Cancer Center describing clinically-relevant results from a study using its lead product, the Parsortix cell separation system, to harvest breast cancer cells in blood for subsequent molecular characterisation. The research confirmed the ability to perform advanced molecular analysis of cells isolated from blood samples using the Parsortix & noted the ability to harvest circulating tumour cells without the use of antibodies.


Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email with “unsubscribe me”.